` CGTX (Cognition Therapeutics Inc) vs NOVO B (Novo Nordisk A/S) Comparison - Alpha Spread

CGTX
vs
NOVO B

Over the past 12 months, CGTX has underperformed NOVO B, delivering a return of -85% compared to the NOVO B's 56% drop.

Valuation Comparison

CGTX Intrinsic Value
HIDDEN
Show
NOVO B Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Cognition Therapeutics Inc
NASDAQ:CGTX
0.2595 USD
Novo Nordisk A/S
CSE:NOVO B
454.2 DKK

Financials Comparison

Growth Over Time
CGTX vs NOVO B

CGTX
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Cognition Therapeutics Inc
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
CGTX vs NOVO B

CGTX
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Cognition Therapeutics Inc
NASDAQ:CGTX
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

CGTX
0%
NOVO B
84.3%

Operating Margin

CGTX
0%
NOVO B
44.6%

Net Margin

CGTX
0%
NOVO B
34.5%

FCF Margin

CGTX
0%
NOVO B
24.5%

ROE

CGTX
-161.9%
NOVO B
88.1%

ROA

CGTX
-106.8%
NOVO B
26.6%

ROIC

CGTX
-1 579.5%
NOVO B
30.4%

ROCE

CGTX
-256.1%
NOVO B
70%

Stocks Performance

Stocks Performance
CGTX vs NOVO B

Loading
CGTX
NOVO B
Add Stock
www.alphaspread.com

Performance Gap
CGTX vs NOVO B

Performance Gap Between CGTX and NOVO B
HIDDEN
Show

Performance By Year
CGTX vs NOVO B

Loading
CGTX
NOVO B
Add Stock
Unlock Full Access to Alpha Spread
Create Free Account